VistaGen Therapeutics, Inc.VTGNNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-42.29M
↓ 86% below average
Average (9y)
$-22.78M
Historical baseline
Range
High:$-4.83M
Low:$-49.93M
CAGR
+27.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $-42.29M | -63.4% |
| 2024 | $-25.87M | +48.2% |
| 2023 | $-49.93M | -9.8% |
| 2022 | $-45.46M | -268.1% |
| 2021 | $-12.35M | +21.6% |
| 2020 | $-15.76M | -7.2% |
| 2019 | $-14.70M | -62.3% |
| 2018 | $-9.06M | -20.8% |
| 2017 | $-7.50M | -55.2% |
| 2016 | $-4.83M | - |